Get the Facts About CME

Concerns about conflict of interest and bias in CME have raised questions about medical education in the minds of clinicians, regulators, and the general public. Is there really a difference between certified continuing medical education and independent promotional activities regulated by the FDA? After reading reports in the press and from legislative hearings, do you wonder if CME is influenced by pharmaceutical funding? Have the appropriate checks and balances been applied to the educational activity in which you are participating to ensure it is balanced and objective? These are all valid questions that as educators, consumers, and stakeholders in the CME community we may, and should, be asking. As these questions are posed, it is critical that the answers accurately reflect current CME practices and not misinformation or misrepresentation...

> Read entire article
> Back to top

Responses from Last Compass Questions™

In the 11.18.08 issue of Clinical Compass™, we asked two questions.

Question #1 was "How often do you speak with your patients about smoking and lung cancer?" and the neuroscienceCME learning community responded:
59.4% - Often
26.0% - Sometimes
10.4% - Rarely
4.2% - Never

Question #2 was "What is your level of knowledge about lung cancer in never-smokers?" and the neuroscienceCME learning community responded:
8.3% - Very knowledgeable
22.9% - Knowledgeable
40.6% - Somewhat knowledgeable
28.1% - I need education on lung cancer in never-smokers

> Back to top

New neuroscienceCME TV
Premieres Tomorrow!

Atypical Antipsychotics in Major Depressive Disorder: When Current Treatments Are Not Enough

Premiere Date: Wednesday, December 3, 2008
Live Broadcast: 12:00-1:00 p.m. ET
"After the Show" live Q&A webcast: 1:02 p.m. ET

Activity Goal
To incorporate the latest evidence-based augmentation treatment strategies to improve outcomes for patients with MDD.

Learning Objectives
At the end of this CE activity, participants should be able to:

• Recognize the importance of remission and recovery as treatment goals for MDD.
• Identify the need for improved treatments and involving the patient in treatment decisions for MDD.
• Evaluate the role of atypical antipsychotics in the treatment of patients with MDD who do not achieve full remission or recovery.

Credit Information
This activity offers CE credit for:

• Physicians (ACCME/AMA PRA Category 1)
• Nurses (CNE)
• Pharmacists (ACPE)
• Psychologists (APA)
• Social Workers (NASW)
• Certified Case Managers (CCMC)

All other clinicians will either receive a CME Attendance Certificate or may choose any of the types of CE credit being offered.

> View activity details
> Add to calendar
> Register now
> Pre-order online
> Back to top

CME Outfitters Wins Alliance for CME "Great Idea" Award

CME Outfitters was selected as winner of the Alliance for CME (ACME) 2009 Medical Education/Communication Company Alliance (MECCA) Member Section Great Idea Award, which recognizes outstanding contributions to the field of CME. Through this award, each of the eight Alliance member sections representing the different providers of CME, like MECCA, recognizes an innovative idea and best practice that has made an impact in the CME profession.

The winning entry was an educational collaboration between CME Outfitters and the American Foundation for Suicide Prevention (AFSP), with funding support provided by the New York State Office of Mental Health. The activity was developed to address the gap in primary care in the recognition and care for patients with major depression in light of the recent FDA black box warning on some antidepressants. The activity, titled “Evaluating and Managing Major Depression: Linking Assessment Measures and Outcomes in Light of the Black Box Warning”, premiered on January 30, 2008. Since its premiere, this activity has reached over 10,000 healthcare providers.

Participation in this award-winning activity is still available through an online archive at www.neuroscienceCME.com/CC272.

> Back to top